The company’s Compensation Committee and Board of Directors approved the grant on July 22, 2024, to be issued in conjunction with the acquisition of The Reiman Agency. Under NASDAQ Listing Rule 5635(c)(4), the grant was made as an inducement material to Mr. Reiman’s entering into an em...
the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of July 16, 2024, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listi...
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on August 5, 2024, the Compensation Committee of Puma’s Board of Directors approved the grant of...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 20, 2023 Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, reported the grant o...
In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed’s Compensation Committee and made as a material inducement to each employee’s entry into employment with the Company. In connection with the commencement of their employment, the employees...
In January, as discussed in this PubCo post, Nasdaq proposed to modify the listing requirements in Rule 5635(d) to - i) change the...
per share of the Company’s common stock as reported by Nasdaq on June 28, 2024. The options were granted from a pool of equity incentives reserved by the Compensation Committee on May 3, 2024, for issuance as inducements to new employees in accordance with Nasdaq Listing Rule 5635(c)(4)...
portfolio, or Reference Asset underlying a security listed under this Rule 5700 Series (including, but not limited to, a significant modification to the index methodology, a change in the index provider, or a change in control of the index provider) is considered a Substitution Listing Event. ...
as a material inducement to employment of 15 newly hired non-executive individuals globally. The RSUs were approved in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement grants consisted of an aggregate of 36,366 RSUs. One-fourth of the RSUs will vest on the firstFebruary 20,May...
portfolio, or Reference Asset underlying a security listed under this Rule 5700 Series (including, but not limited to, a significant modification to the index methodology, a change in the index provider, or a change in control of the index provider) is considered a Substitution Listing Event. ...